Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Genetic Analysis of Benign Familial Epilepsies in the First Year of Life in a Chinese Cohort

Phenotypes and PRRT2 mutations in Chinese families with benign familial infantile epilepsy and infantile convulsions with paroxysmal choreoathetosis

[Spectrum of Mutations in Benign Familial Neonatal-Infantile Epilepsy].

Study of Pathogenic gene spectrum in benign familial infantile epilepsy

Study on gene mutation in benign familial neonatal epilepsy

A Novel Mutation in KCNQ2 Gene Causes Benign Familial Neonatal Convulsions in a Chinese Family

Phenotypes and PRRT2 mutation analysis in families with benign familial infantile epilepsy

Mutation Detection in Candidate Genes for Benign Familial Infantile Seizures on a Novel Locus.

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2

[A Novel Mutation in KCNQ2 Gene Causes Benign Familial Infantile Convulsions (BFIC) in a Chinese Family].

Gene Mutation Analysis In 253 Chinese Children With Unexplained Epilepsy And Intellectual/Developmental Disabilities

Clinical and Genetic Analysis of Two Chinese Families with Benign Familial Neonatal Convulsions

SCN1A, SCN1B , and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus

Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy

[A Novel Mutation of KCNQ2 Gene in a Chinese Family with Benign Familial Neonatal Convulsions].

SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures

Genotype and Phenotype Analysis Using an Epilepsy‐associated Gene Panel in Chinese Pediatric Epilepsy Patients

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

Unexplained Early Infantile Epileptic Encephalopathy in Han Chinese Children: Next-Generation Sequencing and Phenotype Enriching

Gene mutation analysis of 175 Chinese patients with early‐onset epileptic encephalopathy